Evidence map›Paper›PMID 30225207›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2018

Isolation by Miniaturized Culture Chip of an Antarctic bacterium

Fortunato Palma Esposito, Colin J Ingham, Raquel Hurtado-Ortiz, Chantal Bizet, Deniz Tasdemir, Donatella de Pascale

Abstract read
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Description ofMicroorganisms · 2023
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fortunato Palma EspositoInstitute of Protein Biochemistry, National Research Council, Naples, 80131, Italy.
Colin J InghamHoekmine BV, Utrecht, 3584 CS, The Netherlands.
Raquel Hurtado-OrtizCIP-Collection of Institut Pasteur, Department of Microbiology, Institut Pasteur, Paris, 75015, France.
Chantal BizetCIP-Collection of Institut Pasteur, Department of Microbiology, Institut Pasteur, Paris, 75015, France.
Deniz TasdemirGEOMAR Centre for Marine Biotechnology (GEOMAR-Biotech), Research Unit Marine Natural Products Chemistry, GEOMAR Helmholtz Centre for Ocean Research Kiel, Kiel, 24106, Germany.
Donatella de PascaleInstitute of Protein Biochemistry, National Research Council, Naples, 80131, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbes are prolific sources of bioactive molecules; however, the cultivability issue has severely hampered access to microbial diversity. Novel secondary metabolites from as-yet-unknown or atypical microorganisms from extreme environments have realistic potential to lead to new drugs with benefits for human health. Here, we used a novel approach that mimics the natural environment by using a Miniaturized Culture Chip allowing the isolation of several bacterial strains from Antarctic shallow water sediments under near natural conditions. A Gram-negative Antarctic bacterium belonging to the genus

Indexed as

AequorivitaAntarctic bacteriaAnthelminticAntimicrobialGenome miningMiniaturized culture chipMultidrug resistant bacteria

Identifiers

PMID30225207
PMCPMC6139392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.